JOSEPHINE JENNINGS: Open Payments
NPI 1184348849 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 39 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $35 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $267 |
| UCB, Inc. | 3 | $72 |
| TG Therapeutics, Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $20 |
| ARGENX US, INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: QULIPTA, UBRELVY, Nayzilam, BRIUMVI, Briviact, INGREZZA, ULTOMIRIS, Ocrevus Zunovo.
Industry payments across SC — which companies pay providers there.
